Beatriz Ferreira is an Analyst in the Analytical Development and Validation team at Hovione R&D. She holds a bachelor's degree in Biotechnology and joined Hovione in 2022. In 2024, she started a master’s degree in Chemical and Biological Engineering, where she is developing her thesis entitled "Advanced Dissolution Studies with Biomimetic Lung Fluids to Accelerate the Development of Orally Inhaled Dry Powders."
Her research focuses on advanced in vitro non-biorelevant and biorelevant dissolution methodologies using biomimetic lung fluids to improve the prediction of the in vivo performance of inhalation products. This work contributes to the development of Hovione's translational in vitro platform for orally inhaled products, supporting the prediction of clinical bioavailability and accelerating product development.
Beatriz Ferreira MSc work were presented at three international scientific conferences, including a poster at the CRS Annual Meeting in Lisbon, a presentation at AAPS NBC 2026, and an oral presentation at RDD 2026, all focused on translational in vitro approaches for predicting the bioavailability of inhalation products and supporting the development of dry powder inhalation formulations.
